stage II endometrial carcinoma
Showing 1 - 25 of >10,000
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication
Active, not recruiting
- Cancer Survivor
- +6 more
- Communication Intervention
- +5 more
-
Palo Alto, California
- +1 more
Oct 24, 2022
Obesity, Endometrial Carcinoma Trial in Columbus (Gentle yoga therapy, counseling intervention, educational intervention)
Active, not recruiting
- Obesity
- Endometrial Carcinoma
- Gentle yoga therapy
- +4 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jun 3, 2022
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic
Not yet recruiting
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
- (no location specified)
Sep 13, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +4 more
- Akt Inhibitor MK2206
- Laboratory Biomarker Analysis
-
Boston, Massachusetts
- +6 more
Jan 13, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph
Recruiting
- Endometrial Cancer
- +8 more
- Laparoscopic hysterectomy with sentinel lymph node biopsy
-
Istra, Moscow Region, Russian FederationDepartment of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021
Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Everolimus
- +2 more
-
Greeley, Colorado
- +17 more
Jun 13, 2022
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended
Recruiting
- Endometrial Neoplasms
- +4 more
- Indication-extended Fertility-sparing Therapy
-
Beijing, Beijing, ChinaPeking University People's Hosoital
Jul 12, 2023
Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma Trial in Cleveland (lymph node
Terminated
- Stage I Endometrial Carcinoma
- +3 more
- lymph node mapping
- +5 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 26, 2020
Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen
Not yet recruiting
- Metastatic Endometrial Carcinoma
- +7 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma Trial in Houston (Futibatinib, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Endometrial Cancer Trial in Detroit (Quality of life questionnaire)
Recruiting
- Endometrial Cancer
- Quality of life questionnaire
-
Detroit, MichiganHenry Ford Cancer Institute
Feb 22, 2022
Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in
Recruiting
- Recurrent Endometrial Adenocarcinoma
- +8 more
- Ipilimumab
- Nivolumab
-
Iowa City, Iowa
- +9 more
Jan 27, 2023
Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated
Recruiting
- Endometrial Cancer
- +4 more
- Intensity-modulated radiation therapy
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 10, 2023
Advanced Endometrial Adenocarcinoma, Stage III A, B, C Trial in Greenville, Roanoke (Docetaxel and Carboplatin)
Terminated
- Advanced Endometrial Adenocarcinoma, Stage III A, B, C
- Docetaxel and Carboplatin
-
Greenville, South Carolina
- +1 more
Feb 3, 2021
Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)
Not yet recruiting
- Endometrial Carcinoma Stage I
- Atypical Endometrial Hyperplasia
- No intervention
- (no location specified)
Dec 3, 2022
Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)
Not yet recruiting
- Endometrial Cancer
- Vaginal brachytherapy
- +2 more
- (no location specified)
Nov 29, 2022
Endometrial Carcinoma, Obesity, EIN Trial in Boston (CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral)
Recruiting
- Endometrial Carcinoma
- +4 more
- CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
-
Boston, Massachusetts
- +1 more
Aug 2, 2022
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
-
Boston, Massachusetts
- +4 more
Dec 12, 2022
Endometrial Carcinoma, Obese, Overweight Trial in Shanghai (Intensive Lifestyle Intervention (ILI), Megestrol Acetate 160 MG
Recruiting
- Endometrial Carcinoma
- +3 more
- Intensive Lifestyle Intervention (ILI)
- Megestrol Acetate 160 MG Oral Tablet
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Aug 24, 2022
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023